DK413488A - Dna-klon med en basissekvens for human vaevsfaktorinhibitor (tfi) og dna-sekvens, der koder for tfi - Google Patents

Dna-klon med en basissekvens for human vaevsfaktorinhibitor (tfi) og dna-sekvens, der koder for tfi

Info

Publication number
DK413488A
DK413488A DK413488A DK413488A DK413488A DK 413488 A DK413488 A DK 413488A DK 413488 A DK413488 A DK 413488A DK 413488 A DK413488 A DK 413488A DK 413488 A DK413488 A DK 413488A
Authority
DK
Denmark
Prior art keywords
tfi
dna
human tissue
tissue factor
factor inhibitor
Prior art date
Application number
DK413488A
Other languages
English (en)
Other versions
DK413488D0 (da
DK173536B1 (da
Inventor
Jr George John Broze
Kuniko Kusano Kretzmer
Tze-Chein Wun
Original Assignee
Monsanto Co
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22410671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK413488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/123,753 external-priority patent/US4966852A/en
Application filed by Monsanto Co, Univ Washington filed Critical Monsanto Co
Publication of DK413488D0 publication Critical patent/DK413488D0/da
Publication of DK413488A publication Critical patent/DK413488A/da
Priority to DK200001612A priority Critical patent/DK174754B1/da
Application granted granted Critical
Publication of DK173536B1 publication Critical patent/DK173536B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198804134A 1987-11-23 1988-07-22 cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein DK173536B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200001612A DK174754B1 (da) 1987-11-23 2000-10-27 Humane vævsfaktorinhibitor (TFI), antistof med bindingsspecificitet herfor, fremgangsmåde til anvendelse af en TFI-peptid-kolonne til at oprense et antistof og fremgangsmåder til detektion af TFI eller et polypeptid omfattende....

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12375387 1987-11-23
US07/123,753 US4966852A (en) 1987-07-23 1987-11-23 DNA clone of human tissue factor inhibitor

Publications (3)

Publication Number Publication Date
DK413488D0 DK413488D0 (da) 1988-07-22
DK413488A true DK413488A (da) 1989-05-24
DK173536B1 DK173536B1 (da) 2001-02-05

Family

ID=22410671

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804134A DK173536B1 (da) 1987-11-23 1988-07-22 cDNA-sekvens, som koder for modent humant vævsfaktorinhibitor-protein

Country Status (15)

Country Link
EP (1) EP0318451B1 (da)
JP (5) JP2836823B2 (da)
KR (1) KR930000274B1 (da)
AT (1) ATE111518T1 (da)
AU (1) AU604139B2 (da)
CA (1) CA1341223C (da)
DE (1) DE3851511T2 (da)
DK (1) DK173536B1 (da)
ES (1) ES2063769T3 (da)
FI (1) FI93365C (da)
IE (1) IE65393B1 (da)
IL (1) IL87171A (da)
NO (2) NO310466B1 (da)
NZ (1) NZ225535A (da)
PT (1) PT88076B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
ES2086521T3 (es) * 1990-01-25 1996-07-01 Univ Washington Proteina hibrida laci-factor x.
PT98779B (pt) * 1990-08-27 1999-06-30 Monsanto Co Processo para a preparacao de uma composicao anticoagulante contendo inibidor sulfatados e metodos para a sua utilizacao
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
IL161408A0 (en) 2001-10-15 2004-09-27 Chiron Corp Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
ATE477020T1 (de) 2002-06-07 2010-08-15 Dyax Corp Prevention und verringerung von ischemia
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
HUE038243T2 (hu) 2005-12-29 2018-10-29 Dyax Corp Proteáz gátlás
SI2379096T1 (sl) 2008-12-19 2020-03-31 Baxalta GmbH Zaviralci TFPI in postopki uporabe
EP2385843A4 (en) 2009-01-06 2013-02-27 Dyax Corp TREATMENT OF MUZOSITIS WITH CALLICINE INHIBITORS
CA3168591A1 (en) 2010-01-06 2011-07-14 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
WO2011115712A2 (en) 2010-03-19 2011-09-22 Baxter International Inc Tfpi inhibitors and methods of use
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
WO2012171996A1 (en) * 2011-06-15 2012-12-20 F. Hoffmann-La Roche Ag Anti-human epo receptor antibodies and methods of use
DK2827883T3 (da) 2012-03-21 2019-07-29 Baxalta GmbH Tfpi-inhibitorer og fremgangsmåder til anvendelse
EP3387018A1 (en) 2015-12-11 2018-10-17 Dyax Corp. Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor

Also Published As

Publication number Publication date
NZ225535A (en) 1990-11-27
NO310466B1 (no) 2001-07-09
CA1341223C (en) 2001-05-01
EP0318451B1 (en) 1994-09-14
PT88076B (pt) 1993-01-29
FI883487A0 (fi) 1988-07-22
JPH01165383A (ja) 1989-06-29
KR930000274B1 (ko) 1993-01-14
FI883487A (fi) 1989-05-24
ATE111518T1 (de) 1994-09-15
JP2005306875A (ja) 2005-11-04
FI93365C (fi) 1995-03-27
DE3851511D1 (de) 1994-10-20
NO20013608D0 (no) 2001-07-20
NO883270L (no) 1989-05-24
JPH1175875A (ja) 1999-03-23
IL87171A0 (en) 1988-12-30
IE65393B1 (en) 1995-10-18
DK413488D0 (da) 1988-07-22
FI93365B (fi) 1994-12-15
NO20013608L (no) 1989-05-24
AU604139B2 (en) 1990-12-06
JP4025035B2 (ja) 2007-12-19
EP0318451A3 (en) 1990-03-28
KR890007750A (ko) 1989-07-05
JP2002097200A (ja) 2002-04-02
DE3851511T2 (de) 1995-03-30
JP3565714B2 (ja) 2004-09-15
JP2836823B2 (ja) 1998-12-14
IE882243L (en) 1989-05-23
EP0318451A2 (en) 1989-05-31
DK173536B1 (da) 2001-02-05
JP2004201696A (ja) 2004-07-22
PT88076A (pt) 1988-08-01
NO883270D0 (no) 1988-07-22
AU1928788A (en) 1989-05-25
ES2063769T3 (es) 1995-01-16
IL87171A (en) 1995-08-31

Similar Documents

Publication Publication Date Title
DK413488A (da) Dna-klon med en basissekvens for human vaevsfaktorinhibitor (tfi) og dna-sekvens, der koder for tfi
ATE142258T1 (de) Menschlicher gefässpermeabilitätsfaktor
DK450887A (da) Kirurgisk klammepistol
DK414189D0 (da) Aminosyreforbindelse og dens anvendelse
BR8707937A (pt) Protese para osteosintese
DK581788A (da) Hurtigt reetablerende ptfe og fremgangsmaade til fremstilling deraf
NO902156D0 (no) Terapeutisk anvendbar oxadiazolforbindelse og fremgangsmaate for dens fremstilling.
ZA883245B (en) Dna clone of human thrombomodulin
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DK280284A (da) Bicyklo(3,2,1)octancarboxylsyrederivater og fremgangsmaade til fremstilling deraf samt forbindelsernes terapeutiske anvendelse
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DK146789D0 (da) Polypeptider med vaekstfaktoraktivitet og nucleinsyresekvenser, der koder for polypeptiderne
DK396189D0 (da) Peptider med aminosyresekvenser fra prourokinase, deres fremstilling og anvendelse
SE8605216L (sv) Ny medicinsk anvendning
IT8819559A0 (it) Impiego terapeutico dell'acido uridinfosfoglucuronico (udpg_a)come attivatore della glucuronconiugazione del trattamento di epatopie ed itteri.
IT8719433A0 (it) Procedimento per la preparazione di alfafetoproteina umana.
NO880738L (no) Blokkpolymer og anvendelse av denne.
IT1212555B (it) Composizione a base di dobesilato di calcio per il trattamento di malattie cardiache

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK